Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00325130
Status:
COMPLETED
Last Update Posted:
2015-03-12
First Post:
2006-05-11
Brief Title:
Concomitant Use of Gardasil V501 Human Papillomavirus Types 6 11 16 18 Recombinant Vaccine With Combined Diphtheria Tetanus Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents V501-025
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-11
First Submit QC Date:
May 11 2006
Study First Post Date:
2006-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-07-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-02-23
Last Update Post Date:
2015-03-12
Last Update Post Date Type:
ESTIMATED